Comprehensive Ophthalmology Review 2016

David Geffen School of Medicine at UCLA Board Review

Product Details

Download Link:

This post contains protected content. You must contact us to unlock it.

Description:

Comprehensive Ophthalmology Review Course

This board review course, aimed at ophthalmologists and trainees, reviews the clinical essentials of each subspecialty in ophthalmology. The intensive course is a clinically oriented review concentrating on the epidemiology, clinical presentation, diagnosis and management of ophthalmologic disease. The course covers the important clinical principles of ophthalmology and updates any changes to traditional clinical protocols.

Prepare for OKAPs, Board Examinations or MOC

This program will also prepare you for OKAPS, ABO and maintenance recertification examinations. Access the lectures online or via audio MP3 CDs and fit CME into your busy schedule, without travel or time away from your practice.

Accreditation

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA, designates this live activity for a maximum of 24 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation.

Date of Original Release: May 1, 2016
Expiration Date: April 30, 2019
Estimated Time to Complete: 24 hours

Method of Physician Participation: Review video/audio program of conference sessions. Evaluation Methods: Participants will complete a pre-program self-assessment, post-program self-assessment (score of at least 70% or greater is required), and activity evaluation to test knowledge gained from 
reviewing the program, as well as payment of a $30 processing fee.

Disclosure Statement

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed the program is “truly independent” and free of commercial influence. In addition to independence, the FDA requires non-promotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program’s participants. In addition, Accreditation Council for Continuing Medical Education policy now mandates the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.

Learning Objectives

At the completion of this course, you should be able to:

• Identify and describe fundamentals of clinical ophthalmology and all its subspecialties
• Integrate the epidemiology, clinical presentation, diagnosis, and management of ophthalmic disease
• Integrate the latest guidelines for management of ocular disease into clinical practice
• Review for knowledge assessments at all levels (OKAPs, Board Examinations, Maintenance of Certification (MOC))

Intended Audience

Ophthalmologists and trainees

Topics/Speaker:

• Pediatric Ophthalmology (Part 1) – Sherwin Isenberg, MD

• Pediatric Ophthalmology (Part 2) – Sherwin Isenberg, MD

• Strabismus (Part 1) – Kenneth Wright, MD

• Strabismus (Part 2) – Kenneth Wright, MD

• Optics/Refraction (Part 1) – Kevin Miller, MD

• Optics/Refraction (Part 2) – Kevin Miller, MD

• Tumors – Tara McCannel, MD, PhD

• Surgical Retina – Colin McCannel, MD

• Neuro-ophthalmology (Part 1) – Rustum Karanjia, MD, PhD

• Neuro-ophthalmology (Part 2) – Madhu Agarwal, MD

• Cornea (Part 1) – Hugo Hsu, MD

• Cornea (Part 2) – John Irvine, MD

• Cornea/Anterior Uveitis – Olivia Lee, MD

• Eyelids – Anne Kao, MD

• Orbit – Daniel Rootman, MD, MS

• The Lacrimal System – Bruce Becker, MD

• Glaucoma – JoAnn Giaconi, MD

• Retina (Part 1) – SriniVas Sadda, MD

• Retina (Part 2) – David Sarraf, MD

• Retina (Part 3) – Irena Tsui, MD

• Pathology – Todd Mondzelewski, MD